Wedbush Securities Inc. Buys Shares of 4,235 Kewaunee Scientific Co. (NASDAQ:KEQU)

Wedbush Securities Inc. purchased a new stake in shares of Kewaunee Scientific Co. (NASDAQ:KEQU) during the 4th quarter, according to its most recent disclosure with the SEC. The fund purchased 4,235 shares of the technology company’s stock, valued at approximately $262,000.

Several other hedge funds and other institutional investors also recently made changes to their positions in the stock. JPMorgan Chase & Co. grew its holdings in Kewaunee Scientific by 18,000.0% during the 3rd quarter. JPMorgan Chase & Co. now owns 905 shares of the technology company’s stock worth $30,000 after acquiring an additional 900 shares during the last quarter. IFP Advisors Inc bought a new stake in Kewaunee Scientific during the 4th quarter worth approximately $36,000. Morgan Dempsey Capital Management LLC bought a new stake in Kewaunee Scientific during the 4th quarter worth approximately $106,000. Barclays PLC bought a new stake in Kewaunee Scientific during the 3rd quarter worth approximately $121,000. Finally, State Street Corp bought a new stake in Kewaunee Scientific during the 3rd quarter worth approximately $266,000. 32.69% of the stock is owned by institutional investors.

Kewaunee Scientific Trading Up 9.6 %

KEQU opened at $38.31 on Thursday. The firm has a market capitalization of $109.38 million, a price-to-earnings ratio of 6.07 and a beta of 0.59. Kewaunee Scientific Co. has a fifty-two week low of $30.82 and a fifty-two week high of $71.33. The company has a debt-to-equity ratio of 0.45, a current ratio of 2.64 and a quick ratio of 2.13. The company’s 50 day moving average price is $50.85 and its two-hundred day moving average price is $47.35.

Kewaunee Scientific (NASDAQ:KEQU) last issued its quarterly earnings results on Wednesday, March 12th. The technology company reported $1.09 earnings per share (EPS) for the quarter. The firm had revenue of $67.17 million for the quarter. Kewaunee Scientific had a net margin of 9.39% and a return on equity of 25.83%.

Insider Transactions at Kewaunee Scientific

In related news, CEO Thomas David Hull III sold 3,000 shares of the business’s stock in a transaction on Monday, March 24th. The shares were sold at an average price of $45.63, for a total transaction of $136,890.00. Following the transaction, the chief executive officer now owns 37,916 shares in the company, valued at $1,730,107.08. The trade was a 7.33 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CFO Donald T. Gardner III sold 1,257 shares of the business’s stock in a transaction on Friday, January 10th. The shares were sold at an average price of $59.26, for a total transaction of $74,489.82. Following the transaction, the chief financial officer now owns 21,358 shares in the company, valued at $1,265,675.08. The trade was a 5.56 % decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 8,838 shares of company stock worth $423,936. Company insiders own 14.20% of the company’s stock.

Wall Street Analysts Forecast Growth

Separately, StockNews.com lowered shares of Kewaunee Scientific from a “buy” rating to a “hold” rating in a report on Friday, March 14th.

About Kewaunee Scientific

Kewaunee Scientific Corporation designs, manufactures, and installs laboratory, healthcare, and technical furniture and infrastructure products. The company operates through two segments, Domestic and International. Its products include steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, and epoxy resin work surfaces and sinks.